These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23821283)

  • 1. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
    Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
    Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models.
    Van den Berg J; Kwanten L; Roymans D
    Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
    Dunn MC; Knight DA; Waldman WJ
    Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
    PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine
    Mackman RL; Hui HC; Perron M; Murakami E; Palmiotti C; Lee G; Stray K; Zhang L; Goyal B; Chun K; Byun D; Siegel D; Simonovich S; Du Pont V; Pitts J; Babusis D; Vijjapurapu A; Lu X; Kim C; Zhao X; Chan J; Ma B; Lye D; Vandersteen A; Wortman S; Barrett KT; Toteva M; Jordan R; Subramanian R; Bilello JP; Cihlar T
    J Med Chem; 2021 Apr; 64(8):5001-5017. PubMed ID: 33835812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection.
    van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW
    Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children.
    Lagos R; DeVincenzo JP; Muñoz A; Hultquist M; Suzich J; Connor EM; Losonsky GA
    Pediatr Infect Dis J; 2009 Sep; 28(9):835-7. PubMed ID: 19636278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infections: recent prospects for control.
    Sidwell RW; Barnard DL
    Antiviral Res; 2006 Sep; 71(2-3):379-90. PubMed ID: 16806515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells.
    Lundin A; Bergström T; Trybala E
    Methods Mol Biol; 2013; 1030():345-63. PubMed ID: 23821281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
    Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
    J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
    Miller AL; Bowlin TL; Lukacs NW
    J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of a small-molecule inhibitor for respiratory syncytial virus.
    Douglas JL
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):625-39. PubMed ID: 15482225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication.
    Chin VK; Atika Aziz NA; Hudu SA; Harmal NS; Syahrilnizam A; Jalilian FA; Zamberi S
    J Virol Methods; 2016 Oct; 236():117-125. PubMed ID: 27432115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein.
    DeVincenzo J; Tait D; Efthimiou J; Mori J; Kim YI; Thomas E; Wilson L; Harland R; Mathews N; Cockerill S; Powell K; Littler E
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
    Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC
    Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.